Yixintang Pharmaceutical Group Co., Ltd. announced earnings results for the half year ended June 30, 2019. For the half year, the company announced sales was CNY 5,060.022 million compared to CNY 4,291.700 million a year ago. Operating income was CNY 408.766 million compared to CNY 359.399 million a year ago. Net income was CNY 337.236 million compared to CNY 292.457 million a year ago. Basic earnings per share from continuing operations was CNY 0.594 compared to CNY 0.5151 a year ago. Diluted earnings per share from continuing operations was CNY 0.5921 compared to CNY 0.5151 a year ago.